Table 3.
Dependent variable | Subgroup | No. of participants | No. of symptoms | Prevalence | Crude ORsa | Adjusted ORsb | P for |
---|---|---|---|---|---|---|---|
(%) | (95% CI) | (95% CI) | interaction | ||||
Depressive symptoms | Total sample | 1629 | 423 | 25.97 | |||
PSU | 953 | 334 | 35.05 | 3.37(2.45-4.64) | 3.14(2.26–4.37) | 0.015 | |
Non-PSU | 676 | 89 | 13.17 | 1 | 1 | ||
Online group | 788 | 236 | 29.95 | ||||
PSU | 495 | 205 | 41.41 | 4.31(2.64-5.67) | 4.66(2.83–6.75) | ||
Non-PSU | 293 | 31 | 10.58 | 1 | 1 | ||
Face-to-face group | 841 | 187 | 22.24 | ||||
PSU | 458 | 129 | 28.17 | 2.39(2.38-4.85) | 2.33(2.31–4.82) | ||
Non-PSU | 383 | 58 | 15.14 | 1 | 1 | ||
Anxiety symptoms | Total sample | 1629 | 357 | 21.92 | |||
PSU | 953 | 264 | 27.70 | 3.51(2.42-5.07) | 3.73(2.13–4.59) | 0.021 | |
Non-PSU | 676 | 93 | 13.76 | 1 | |||
Online group | 788 | 198 | 25.13 | ||||
PSU | 495 | 163 | 32.93 | 5.67(3.46-9.09) | 6.05(3.49–9.67) | ||
Non-PSU | 293 | 35 | 11.95 | 1 | 1 | ||
Face-to-face group | 841 | 159 | 18.91 | ||||
PSU | 458 | 101 | 22.05 | 3.09(2.04-4.67) | 2.94(1.93–4.49) | ||
Non-PSU | 383 | 58 | 15.14 | 1 | 1 | ||
Insomnia symptoms | Total sample | 1629 | 1189 | 72.99 | |||
PSU | 953 | 761 | 79.85 | 2.97(2.27-3.88) | 2.96(2.23–3.92) | 0.589 | |
Non-PSU | 676 | 428 | 63.31 | 1 | 1 | ||
Online group | 788 | 598 | 75.89 | ||||
PSU | 495 | 415 | 83.84 | 3.24(2.87-5.35) | 3.29(2.87–5.72) | ||
Non-PSU | 293 | 183 | 62.46 | 1 | 1 | ||
Face-to-face group | 841 | 591 | 70.27 | ||||
PSU | 458 | 346 | 75.55 | 2.87(2.13-3.87) | 2.86(2.11–3.89) | ||
Non-PSU | 383 | 245 | 63.97 | 1 | 1 |
PSU, problematic smartphone use; OR, odds ratio.
Non-adjusted model.
Adjusted for age, sex, grade, educational level, residence, satisfaction, and exercise habits.
Participants with no PSU comprised the reference groups.